FindTrial
Sign In

Changzhou coronary heart disease intensive lipid-lowering intervention study

Changzhou coronary atherosclerotic heart disease cohort construction and intensive lipid-lowering intervention

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300069827
Enrollment
Unknown
Registered
2023-03-27
Start date
2023-04-01
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary atherosclerotic heart disease

Interventions

intensive lipid management:Through lifestyle drug management, blood lipids are strengthened to achieve target values
Daily lipid management group:Daily follow-up, telephone follow-up every 6 months, outpatient follow-up every 12 months

Sponsors

Changzhou Second People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: Patients diagnosed with coronary heart disease in Changzhou Second People's Hospital; Coronary heart disease: clear coronary angiography or coronary CT results, coronary stenosis of more than 50%; No previous surgery, but consistent with a diagnosis of myocardial infarction.

Exclusion criteria

Exclusion criteria: Patients who refused 2-year follow-up

Design outcomes

Primary

MeasureTime frame
Lipid profile;—

Secondary

MeasureTime frame
Medication;adverse event;Major Adverse Cardiovascular Events;—

Countries

China

Contacts

Public ContactYuan Ji

Changzhou Second People's Hospital

evexiang24@163.com13196788055

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026